CoChat

Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features

Open access

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Abstract

Lung cancer is the most prevalent cancer worldwide, and histopathological assessment is indispensable for its diagnosis. However, human evaluation of pathology slides cannot accurately predict patients’ prognoses. In this study, we obtain 2,186 haematoxylin and eosin stained histopathology whole-slide images of lung adenocarcinoma and squamous cell carcinoma patients from The Cancer Genome Atlas (TCGA), and 294 additional images from Stanford Tissue Microarray (TMA) Database. We extract 9,879 quantitative image features and use regularized machine-learning methods to select the top features and to distinguish shorter-term survivors from longer-term survivors with stage I adenocarcinoma ( P <0.003) or squamous cell carcinoma ( P =0.023) in the TCGA data set. We validate the survival prediction framework with the TMA cohort ( P <0.036 for both tumour types). Our results suggest that automatically derived image features can predict the prognosis of lung cancer patients and thereby contribute to precision oncology. Our methods are extensible to histopathology images of other organs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms12474

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Quantitative image features accurately distinguished malignancies from adjacent dense normal tissues. (a) ROC curves for classifying lung adenocarcinoma versus adjacent dense normal tissues in the TCGA test set. Classifiers with 80 features attained average AUC of 0.81. (b) ROC curves for classifying lung squamous cell carcinoma from adjacent dense normal tissues in the TCGA test set. Classifiers with 80 features attained average AUC of 0.85. The performance of different classifiers is shown. CIT, conditional inference trees; ROC, receiver operator characteristics.
Figure 1 Quantitative image features accurately distinguished malignancies from adjacent dense normal tissues. (a) ROC curves for classifying lung adenocarcinoma versus adjacent dense normal tissues in the TCGA test set. Classifiers with 80 features attained average AUC of 0.81. (b) ROC curves for classifying lung squamous cell carcinoma from adjacent dense normal tissues in the TCGA test set. Classifiers with 80 features attained average AUC of 0.85. The performance of different classifiers is shown. CIT, conditional inference trees; ROC, receiver operator characteristics.CC BY · PubMed Central
Figure 2 Quantitative image features successfully distinguished histopathology images of lung adenocarcinoma from those of lung squamous cell carcinoma. (a) ROC curves for classifying the two malignancies in the TCGA test set. Most classifiers achieved AUC>0.7. (b) ROC curves for classifying the two malignancies in the TMA test set. Most classifiers achieved AUC >0.75, indicating that our informatics pipeline was successfully validated in the independent TMA data set. The performance of different classifiers is shown. CIT, conditional inference trees; ROC, receiver operator characteristics.
Figure 2 Quantitative image features successfully distinguished histopathology images of lung adenocarcinoma from those of lung squamous cell carcinoma. (a) ROC curves for classifying the two malignancies in the TCGA test set. Most classifiers achieved AUC>0.7. (b) ROC curves for classifying the two malignancies in the TMA test set. Most classifiers achieved AUC >0.75, indicating that our informatics pipeline was successfully validated in the independent TMA data set. The performance of different classifiers is shown. CIT, conditional inference trees; ROC, receiver operator characteristics.CC BY · PubMed Central
Figure 3 Quantitative image features predicted the survival outcomes of stage I lung adenocarcinoma patients. (a) Kaplan–Meier curves of lung adenocarcinoma patients stratified by tumour stage. Patients with higher stages tended to have worse prognosis (log-rank test P value <0.001 in TCGA data set, log-rank test P=0.0068 in TMA data set). However, the survival outcomes varied widely. (left: TCGA data set, right: TMA data set). (b) Kaplan–Meier curves of stage I lung adenocarcinoma patients stratified by tumour grade. Tumour grade did not significantly correlate with survival (left: TCGA data set, log-rank test P value=0.06; right: TMA data set, log-rank test P value=0.0502). (c) Kaplan–Meier curves of stage I lung adenocarcinoma patients stratified using quantitative image features. Image features predicted the survival outcomes. Elastic net-Cox proportional hazards model categorized patients into two prognostic groups, with a statistically significant difference in their survival outcomes in the TCGA test set (log-rank test P value=0.0023). (d) The same classification workflow was validated in the TMA data set, with comparable prediction performance. (log-rank test P value=0.028). (e) Sample image of stage I adenocarcinoma with long survival. This patient suffered from stage IB, grade 3 lung adenocarcinoma, and survived more than 99 months after diagnosis. Our classifier correctly predicted the patient as a long survivor. (f) Sample image of stage I adenocarcinoma with short survival. This patient suffered from stage IB, grade 3 lung adenocarcinoma, and survived less than 12 months after diagnosis. Our classifier correctly predicted the patient as a short survivor.
Figure 3 Quantitative image features predicted the survival outcomes of stage I lung adenocarcinoma patients. (a) Kaplan–Meier curves of lung adenocarcinoma patients stratified by tumour stage. Patients with higher stages tended to have worse prognosis (log-rank test P value <0.001 in TCGA data set, log-rank test P=0.0068 in TMA data set). However, the survival outcomes varied widely. (left: TCGA data set, right: TMA data set). (b) Kaplan–Meier curves of stage I lung adenocarcinoma patients stratified by tumour grade. Tumour grade did not significantly correlate with survival (left: TCGA data set, log-rank test P value=0.06; right: TMA data set, log-rank test P value=0.0502). (c) Kaplan–Meier curves of stage I lung adenocarcinoma patients stratified using quantitative image features. Image features predicted the survival outcomes. Elastic net-Cox proportional hazards model categorized patients into two prognostic groups, with a statistically significant difference in their survival outcomes in the TCGA test set (log-rank test P value=0.0023). (d) The same classification workflow was validated in the TMA data set, with comparable prediction performance. (log-rank test P value=0.028). (e) Sample image of stage I adenocarcinoma with long survival. This patient suffered from stage IB, grade 3 lung adenocarcinoma, and survived more than 99 months after diagnosis. Our classifier correctly predicted the patient as a long survivor. (f) Sample image of stage I adenocarcinoma with short survival. This patient suffered from stage IB, grade 3 lung adenocarcinoma, and survived less than 12 months after diagnosis. Our classifier correctly predicted the patient as a short survivor.CC BY · PubMed Central
Figure 4 Quantitative image features predicted the survival outcomes of lung squamous cell carcinoma patients. (a) Kaplan–Meier curves of lung squamous cell carcinoma patients stratified by tumour stage. Although patients with higher stages generally have worse outcomes, the trend was not statistically significant (left: TCGA data set, log-rank test P value=0.216; right: TMA data set, log-rank test P value=0.388). (b) Kaplan–Meier curves of stage I lung squamous cell carcinoma patients stratified by tumour grade. Tumour grade did not significantly correlate with survival. (left: TCGA data set, log-rank test P value=0.847; right: TMA data set, log-rank test P value=0.964). (c) Kaplan–Meier curves of lung squamous cell carcinoma patients stratified using quantitative image features. The image features predicted the survival outcomes. Elastic net-Cox proportional hazards model categorized patients into two prognostic groups, with a statistically significant difference in their survival in the TCGA test set (log-rank test P value=0.023). (d) The same classification workflow was validated in the TMA data set, with comparable prediction performance. (log-rank test P value=0.035). (e) Sample image of lung squamous cell carcinoma in a patient with long survival. This patient suffered from stage I, grade 1 lung squamous cell carcinoma, and survived more than 70 months after diagnosis. Our classifier correctly predicted the patient as a long survivor. (f) Sample image of squamous cell carcinoma in a patient with short survival. This patient suffered from stage I, grade 1 lung squamous cell carcinoma, and only survived 12.4 months after diagnosis. Our classifier correctly predicted the patient as a short survivor.
Figure 4 Quantitative image features predicted the survival outcomes of lung squamous cell carcinoma patients. (a) Kaplan–Meier curves of lung squamous cell carcinoma patients stratified by tumour stage. Although patients with higher stages generally have worse outcomes, the trend was not statistically significant (left: TCGA data set, log-rank test P value=0.216; right: TMA data set, log-rank test P value=0.388). (b) Kaplan–Meier curves of stage I lung squamous cell carcinoma patients stratified by tumour grade. Tumour grade did not significantly correlate with survival. (left: TCGA data set, log-rank test P value=0.847; right: TMA data set, log-rank test P value=0.964). (c) Kaplan–Meier curves of lung squamous cell carcinoma patients stratified using quantitative image features. The image features predicted the survival outcomes. Elastic net-Cox proportional hazards model categorized patients into two prognostic groups, with a statistically significant difference in their survival in the TCGA test set (log-rank test P value=0.023). (d) The same classification workflow was validated in the TMA data set, with comparable prediction performance. (log-rank test P value=0.035). (e) Sample image of lung squamous cell carcinoma in a patient with long survival. This patient suffered from stage I, grade 1 lung squamous cell carcinoma, and survived more than 70 months after diagnosis. Our classifier correctly predicted the patient as a long survivor. (f) Sample image of squamous cell carcinoma in a patient with short survival. This patient suffered from stage I, grade 1 lung squamous cell carcinoma, and only survived 12.4 months after diagnosis. Our classifier correctly predicted the patient as a short survivor.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

Items 201–300 of 983

Metadata

Authors
Yu, K.-H., Zhang, C., Berry, G. J., Altman, R. B., Ré, C., Rubin, D. L., & Snyder, M.
Affiliations
  • Stanford University (US)
  • Stanford Medicine (US)
Corresponding author
  • Rubin, Daniel L.
  • Snyder, Michael
Venue
Nature Communications
Published
2016-08-16
Volume
7
Issue
1
Pages
12474-12474
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2514628397
Cited by
972
References
61
Citations by year
2026: 40 · 2025: 87 · 2024: 104 · 2023: 106 · 2022: 135 · 2021: 125 · 2020: 119 · 2019: 120 · 2018: 83 · 2017: 47 · 2016: 4
FWCI
69.74
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Howard Hughes Medical Institute
  • National Institutes of Health (U01¿CA¿142555)
  • National Human Genome Research Institute (P50HG007735)
  • National Cancer Institute (U01CA142555, U24CA160036)
  • National Institute of General Medical Sciences (R35GM142879)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Image Retrieval and Classification Techniques
Keywords
non-small cell lung cancer, outcome prediction, lung adenocarcinoma, squamous cell carcinoma, survival prediction, feature selection, precision oncology, H&E staining
MeSH terms
Machine Learning, Adenocarcinoma, Aged, Carcinoma, Squamous Cell, Female, Humans, Image Processing, Computer-Assisted, Lung, Lung Neoplasms, Male, Middle Aged, Pathology, Clinical, Prognosis, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.